Core Scientific, Inc. CORZ Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$347.19M— | —— | -$146.66M+84.3% | -$936.8M-263% | $576.25M+298% | ||
| $16.65M+18.1% | $14.1M-13.7% | $16.33M-12.9% | $18.76M-4.9% | $19.73M-24.2% | ||
| $17.76M-36.4% | $27.94M-6.7% | $29.95M+23.9% | $24.17M+49.3% | $16.19M-32.5% | ||
| -$13.64M-430% | -$2.58M+12.2% | -$2.93M+29.6% | -$4.17M-69,333% | -$6K+96.0% | ||
| $5.87M-79.3% | $28.4M+2,392% | -$1.24M+40.5% | -$2.08M+85.4% | -$14.3M-2,162% | ||
| -$16.36M+61.4% | -$42.34M-222% | $34.73M+378% | -$12.5M-561% | $2.71M-94.2% | ||
| —— | —— | —— | —— | —— | ||
| $3.17M+5.0% | $3.02M+6.1% | $2.84M+4.3% | $2.73M+1.9% | $2.68M-14.1% | ||
| $1.68M— | —— | —— | —— | $1.73M— | ||
| -$10.11M— | —— | —— | -$33.44M-420% | $10.46M-43.5% | ||
| $249.88M+63.2% | $153.07M+16.2% | $131.78M+243% | $38.44M+185% | -$45.04M-426% | ||
| $389.23M+41.6% | $274.81M+12.4% | $244.49M+94.5% | $125.72M+49.7% | $83.98M+192% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $55K+7.8% | $51K— | —— | —— | $36K-10.0% | ||
| $2.63M+71.6% | $1.53M+494% | $258K-84.6% | $1.67M— | $0— | ||
| $0— | —— | —— | —— | $5M— | ||
| -$386.65M-41.5% | -$273.33M-7.5% | -$254.36M-105% | -$124.05M-39.4% | -$89.02M-209% | ||
| $995M— | $0— | $0— | $0— | $0+100% | ||
| $0— | —— | —— | $4.66M+17.8% | $3.96M-69.4% | ||
| $1.1M— | $0-100% | $547K-11.2% | $616K+21.0% | $509K-28.3% | ||
| $882K— | —— | —— | —— | $0— | ||
| $971.38M+4,554% | -$21.81M-310% | -$5.32M+83.2% | -$31.77M-657% | -$4.2M-101% | ||
| $834.61M+687% | -$142.07M-11.1% | -$127.9M-9.0% | -$117.38M+15.1% | -$138.26M-124% | ||
| $1.68M— | —— | —— | —— | $1.73M— | ||
| -$6.56M+89.4% | -$61.67M-663% | $10.96M-63.2% | $29.8M+379% | -$10.69M-1,228% | ||
| -$1.04M— | —— | -$777K+94.3% | -$13.72M-207% | $12.82M+571% | ||
| -$10.11M— | —— | —— | -$33.44M-420% | $10.46M-43.5% | ||
| $35.8M+505% | $5.92M+23.1% | $4.81M-39.7% | $7.97M+94.5% | $4.1M-66.3% | ||
| $3.17M+5.0% | $3.02M+6.1% | $2.84M+4.3% | $2.73M+1.9% | $2.68M-14.1% | ||
| $208.25M— | $0— | $0— | $0— | $0-100% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $30.12M-28.8% | $42.31M-26.6% | $57.63M-7.5% | $62.33M-7.6% | $67.44M-30.0% | ||
| $0— | —— | —— | —— | $5M— | ||
| $55K+7.8% | $51K— | —— | —— | $36K-10.0% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $2.63M+71.6% | $1.53M+494% | $258K-84.6% | $1.67M— | $0— | ||
| $1.1M— | $0-100% | $547K-11.2% | $616K+21.0% | $509K-28.3% | ||
| $21.72M-17.5% | $26.32M— | —— | —— | $0— | ||
| $882K— | —— | —— | —— | $0— | ||
| $81K-98.4% | $5.17M+363% | $1.12M+207% | $364K+36.8% | $266K-91.0% | ||
| —— | —— | —— | —— | —— | ||
| -$139.35M-14.5% | -$121.74M-8.0% | -$112.71M-29.1% | -$87.28M+32.4% | -$129.02M-763% | ||
| -$139.35M-14.5% | -$121.74M-8.0% | -$112.71M-29.1% | -$87.28M+32.4% | -$129.02M-763% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Core Scientific, Inc. generate?
- Core Scientific, Inc. (CORZ) generated $573.2M in operating cash flow over the trailing twelve months.
- What is Core Scientific, Inc.'s free cash flow?
- After $1.0B of capital expenditures, Core Scientific, Inc.'s free cash flow was -$461.1M over the trailing twelve months, down 169.1% year over year.
- Where does Core Scientific, Inc.'s cash flow data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
